This paper compared cycle threshold (CT) values for microRNA (miRNA, miR) with and without heparinase treatments of RNA from heparinized and non-heparinized myocardial infarct patients and investigated the correlation between hemolysis and levels of individual miRNA and total RNA concentrations. Different methods of measuring RNA concentration and hemolysis were also compared.
Practical Procedures for Improving Detection of Circulating miRNAs in Cardiovascular Diseases.
Chen CC, Peng CC, Fan PC, Chu PH, Chang YS, Chang CH
Purpose
Conclusion
Heparinase treatment decreased the CT value of miRNAs in serum from heparinized patients but did not cause a noticeable shift in the CT values of miRNAs in serum from non-heparinized patients. miR-451a to miR-23a-3p ratios did not show a trend with visual hemolysis scores but a slight increase in hemoglobin (absorbance at 414 nm) was observed with increased visual hemolysis. RNA concentration was weakly correlated with hemoglobin absorbance with higher mean RNA concentration in hemolyzed specimens than non-hemolyzed specimens. After normalization to cel-miR-39 and adjustment for RNA concentration, levels of miR-16, miR-19b, miR-140, miR-451a, and miR-532 were significantly higher in hemolyzed specimens than non-hemolyzed serum and levels of each miRNA was weakly to modestly correlated with hemolysis.
RNA concentrations as quantified by RiboGreen were strongly correlated with those by bioanalyzer. Levels of the spiked-in cel-miR-39 were only modestly correlated with RNA concentration.
Studies (1)
Purpose
This study compared cycle threshold (CT) values for microRNA (miRNA, miR) with and without heparinase treatments of RNA from heparinized and non-heparinized myocardial infarct patients and investigated the correlation between hemolysis and levels of individual miRNA and total RNA concentrations. Different methods of measuring RNA concentration and hemolysis were also compared. Blood was obtained from 89 patients with acute myocardial infarction. The patients with ST elongation received intravenous unfractionated heparin (initial bolus of 60 IU/kg followed by 12 IU/kg/h) while those without ST elongation were treated with enoxaparin (initial bolus of 30 mg enoxaparin followed by 1 mg/kg). Blood was considered heparinized if the patient was treated with either heparin or enoxaparin in the 24 h proceeding blood collection. Serum was obtained by centrifugation of blood at 2000 x g for 10 min and frozen at -80°C. Hemolysis was detected in thawed serum by measuring the absorbance at 414 nm. Thawed serum was mixed with QIAzol Lysis Reagent and cel-miR-39 spike-in control. RNA was extracted using the miRNeasy Mini Kit and quantified using Quant-iT RiboGreen RNA Assay and spectrophotometry. Select RNAs were further evaluated by bioanalyzer. RNA was treated with 0.5 U heparinase I for 1 h at 25°C or left untreated prior to TaqMAN real-time RT-PCR of 37 miRNAs. CT values of each miRNA were normalized to the difference in the median and sample cel-miR-39 CT values followed by additional adjustment for concentration (log2 concentration in sample/median concentration). miRNAs with normalized CT values >37 were considered not detectable.
Summary of Findings
Heparinase treatment decreased the CT value of cel-miR-39 in serum from heparinized patients by a median of 2.37 cycles (range 0.35–21.01) but the CT value of cel-miR-39 in serum from non-heparinized patients only changed by a median of 0.57 cycles (range 0.10-0.71 cycles). Similarly, heparinase treatment decreased the CT values of the other 36 miRNAs investigated in serum from heparin-treated patients but did not cause a noticeable shift in the CT values of miRNA in serum from non-heparinized patients. Importantly, following heparinase treatment, CT values were very strongly correlated (R2=0.96-0.97) between replicate RNA extractions, indicating that heparinase removed inhibition without affecting accuracy of real-time RT-PCR quantification. miR-451a to miR-23a-3p ratios did not show a trend with visual hemolysis scores but a slight increase in hemoglobin (absorbance at 414 nm) was observed with increased visual hemolysis. RNA concentration was weakly correlated with hemoglobin absorbance (r=0.251, P<0.05) and mean RNA concentration was higher in hemolyzed specimens (absorbance at 414 nm >0.3) than in non-hemolyzed specimens (P<0.05). After normalization to cel-miR-39 and adjustment for RNA concentration, levels of miR-16, miR-19b, miR-140, miR-451a, and miR-532 were significantly higher in hemolyzed specimens than non-hemolyzed serum and levels of each miRNA was weakly to modestly correlated with hemolysis (absorbance at 414 nm r=0.271-4.28, P<0.05 all).
RNA concentrations as quantified by RiboGreen were strongly correlated with those by bioanalyzer (r=0.855, P<0.001). Levels of the spiked-in cel-miR-39 were only modestly correlated with RNA concentration (r=0.438, P<0.001).
Biospecimens
FluidBloodFluidPlasmaPreservation Types
FrozenDiagnoses
Cardiovascular DiseasePlatforms
RNAAutomated electrophoresis/BioanalyzerRNAFluorometryRNAReal-time qRT-PCRProteinMacroscopic observationProteinSpectrophotometryPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Other drugs Heparinized patientNon-heparinized patientReal-time qRT-PCR Specific Targeted nucleic acid 37 miRNA panelReal-time qRT-PCR Specific Technology platform BioanalyzerFluorometerMacroscopic observationSpectrophotometerReal-time qRT-PCR Specific Template modification Heparinase treatedUntreatedFluorometry Specific Technology platform Bioanalyzer